| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACKR3
|
atypical chemokine receptor 3
|
|
ACSF3
|
acyl-CoA synthetase family member 3
|
|
ADAM28
|
ADAM metallopeptidase domain 28
|
|
ADGRE5
|
adhesion G protein-coupled receptor E5
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
AFF1
|
AF4/FMR2 family, member 1
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AIFM1
|
apoptosis-inducing factor, mitochondrion-associated, 1
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ANGPT2
|
angiopoietin 2
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
AQP4
|
aquaporin 4
|
|
ARID3A
|
AT rich interactive domain 3A (BRIGHT-like)
|
|
ATF5
|
activating transcription factor 5
|
|
ATG5
|
autophagy related 5
|
|
ATM
|
ATM serine/threonine kinase
|
|
AURKB
|
aurora kinase B
|
|
AUTS2
|
autism susceptibility candidate 2
|
|
B2M
|
beta-2-microglobulin
|
|
BACH2
|
BTB and CNC homology 1, basic leucine zipper transcription factor 2
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAG3
|
BCL2-associated athanogene 3
|
|
BANK1
|
B-cell scaffold protein with ankyrin repeats 1
|
|
BAX
|
BCL2-associated X protein
|
|
BBC3
|
BCL2 binding component 3
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL11A
|
B-cell CLL/lymphoma 11A (zinc finger protein)
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2A1
|
BCL2-related protein A1
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL2L14
|
BCL2-like 14 (apoptosis facilitator)
|
|
BCL3
|
B-cell CLL/lymphoma 3
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCL7A
|
B-cell CLL/lymphoma 7A
|
|
BIK
|
BCL2-interacting killer (apoptosis-inducing)
|
|
BIRC2
|
baculoviral IAP repeat containing 2
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BIRC7
|
baculoviral IAP repeat containing 7
|
|
BLID
|
BH3-like motif containing, cell death inducer
|
|
BLK
|
BLK proto-oncogene, Src family tyrosine kinase
|
|
BLM
|
Bloom syndrome, RecQ helicase-like
|
|
BLNK
|
B-cell linker
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRD2
|
bromodomain containing 2
|
|
BRD4
|
bromodomain containing 4
|
|
BTG1
|
B-cell translocation gene 1, anti-proliferative
|
|
BTG2
|
BTG family, member 2
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
BTLA
|
B and T lymphocyte associated
|
|
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma
|
|
CARD11
|
caspase recruitment domain family, member 11
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CBFA2T3
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 3
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
|
CCL22
|
chemokine (C-C motif) ligand 22
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CCND3
|
cyclin D3
|
|
CCNE1
|
cyclin E1
|
|
CCNH
|
cyclin H
|
|
CCR6
|
chemokine (C-C motif) receptor 6
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD14
|
CD14 molecule
|
|
CD160
|
CD160 molecule
|
|
CD180
|
CD180 molecule
|
|
CD19
|
CD19 molecule
|
|
CD1D
|
CD1d molecule
|
|
CD200
|
CD200 molecule
|
|
CD209
|
CD209 molecule
|
|
CD22
|
CD22 molecule
|
|
CD27
|
CD27 molecule
|
|
CD274
|
CD274 molecule
|
|
CD37
|
CD37 molecule
|
|
CD38
|
CD38 molecule
|
|
CD4
|
CD4 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
|
CD5
|
CD5 molecule
|
|
CD7
|
CD7 molecule
|
|
CD70
|
CD70 molecule
|
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha
|
|
CD79B
|
CD79b molecule, immunoglobulin-associated beta
|
|
CD81
|
CD81 molecule
|
|
CD8A
|
CD8a molecule
|
|
CD99
|
CD99 molecule
|
|
CDA
|
cytidine deaminase
|
|
CDC7
|
cell division cycle 7
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CES2
|
carboxylesterase 2
|
|
CFAP69
|
cilia and flagella associated protein 69
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CHEK2
|
checkpoint kinase 2
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CLLU1
|
chronic lymphocytic leukemia up-regulated 1
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
|
CREBBP
|
CREB binding protein
|
|
CREBL2
|
cAMP responsive element binding protein-like 2
|
|
CRLF2
|
cytokine receptor-like factor 2
|
|
CSNK1A1
|
casein kinase 1, alpha 1
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CT45A1
|
cancer/testis antigen family 45, member A1
|
|
CTGF
|
connective tissue growth factor
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CXCR5
|
chemokine (C-X-C motif) receptor 5
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DBN1
|
drebrin 1
|
|
DCLRE1C
|
DNA cross-link repair 1C
|
|
DCN
|
decorin
|
|
DIABLO
|
diablo, IAP-binding mitochondrial protein
|
|
DLX3
|
distal-less homeobox 3
|
|
DMD
|
dystrophin
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DOCK8
|
dedicator of cytokinesis 8
|
|
DOK1
|
docking protein 1, 62kDa (downstream of tyrosine kinase 1)
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DUSP16
|
dual specificity phosphatase 16
|
|
EBF1
|
early B-cell factor 1
|
|
EBI3
|
Epstein-Barr virus induced 3
|
|
EED
|
embryonic ectoderm development
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN3
|
egl-9 family hypoxia-inducible factor 3
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
|
EP300
|
E1A binding protein p300
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
EPO
|
erythropoietin
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ESRRA
|
estrogen-related receptor alpha
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
ETV6
|
ets variant 6
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FABP7
|
fatty acid binding protein 7, brain
|
|
FAM167A
|
family with sequence similarity 167, member A
|
|
FAS
|
Fas cell surface death receptor
|
|
FBXO10
|
F-box protein 10
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FCRL1
|
Fc receptor-like 1
|
|
FCRL2
|
Fc receptor-like 2
|
|
FCRL3
|
Fc receptor-like 3
|
|
FCRL4
|
Fc receptor-like 4
|
|
FCRL5
|
Fc receptor-like 5
|
|
FCRLA
|
Fc receptor-like A
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FHIT
|
fragile histidine triad
|
|
FIGF
|
c-fos induced growth factor (vascular endothelial growth factor D)
|
|
FLCN
|
folliculin
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FMOD
|
fibromodulin
|
|
FNIP1
|
folliculin interacting protein 1
|
|
FOXM1
|
forkhead box M1
|
|
FOXO1
|
forkhead box O1
|
|
FOXP1
|
forkhead box P1
|
|
FOXP3
|
forkhead box P3
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GAB1
|
GRB2-associated binding protein 1
|
|
GAD2
|
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)
|
|
GAS5
|
growth arrest-specific 5 (non-protein coding)
|
|
GAS6
|
growth arrest-specific 6
|
|
GATA2
|
GATA binding protein 2
|
|
GCSAM
|
germinal center-associated, signaling and motility
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLI2
|
GLI family zinc finger 2
|
|
GLI3
|
GLI family zinc finger 3
|
|
GNA13
|
guanine nucleotide binding protein (G protein), alpha 13
|
|
GNLY
|
granulysin
|
|
GPR183
|
G protein-coupled receptor 183
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
GSTA1
|
glutathione S-transferase alpha 1
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC3
|
histone deacetylase 3
|
|
HDAC6
|
histone deacetylase 6
|
|
HES1
|
hes family bHLH transcription factor 1
|
|
HGFAC
|
HGF activator
|
|
HIC1
|
hypermethylated in cancer 1
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIST3H3
|
histone cluster 3, H3
|
|
HIST4H4
|
histone cluster 4, H4
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-DOA
|
major histocompatibility complex, class II, DO alpha
|
|
HLA-DOB
|
major histocompatibility complex, class II, DO beta
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMOX1
|
heme oxygenase 1
|
|
HOXA10
|
homeobox A10
|
|
HOXA7
|
homeobox A7
|
|
HOXA9
|
homeobox A9
|
|
HOXB4
|
homeobox B4
|
|
HSPA8
|
heat shock 70kDa protein 8
|
|
HTRA2
|
HtrA serine peptidase 2
|
|
HVCN1
|
hydrogen voltage gated channel 1
|
|
ID3
|
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein
|
|
ID4
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFN1@
|
interferon, type 1, cluster
|
|
IFNAR1
|
interferon (alpha, beta and omega) receptor 1
|
|
IFNG
|
interferon, gamma
|
|
IFNGR1
|
interferon gamma receptor 1
|
|
IGFBP7
|
insulin-like growth factor binding protein 7
|
|
IGH
|
immunoglobulin heavy locus
|
|
IGHD
|
immunoglobulin heavy constant delta
|
|
IGHM
|
immunoglobulin heavy constant mu
|
|
IGHV3-7
|
immunoglobulin heavy variable 3-7
|
|
IGHV4-34
|
immunoglobulin heavy variable 4-34
|
|
IGHV4-59
|
immunoglobulin heavy variable 4-59
|
|
IGK
|
immunoglobulin kappa locus
|
|
IGL
|
immunoglobulin lambda locus
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IL10
|
interleukin 10
|
|
IL10RA
|
interleukin 10 receptor, alpha
|
|
IL10RB
|
interleukin 10 receptor, beta
|
|
IL11
|
interleukin 11
|
|
IL12RB2
|
interleukin 12 receptor, beta 2
|
|
IL13
|
interleukin 13
|
|
IL15RA
|
interleukin 15 receptor, alpha
|
|
IL18
|
interleukin 18
|
|
IL2
|
interleukin 2
|
|
IL21
|
interleukin 21
|
|
IL21R
|
interleukin 21 receptor
|
|
IL22
|
interleukin 22
|
|
IL24
|
interleukin 24
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL3RA
|
interleukin 3 receptor, alpha (low affinity)
|
|
IL4
|
interleukin 4
|
|
IL4I1
|
interleukin 4 induced 1
|
|
IL4R
|
interleukin 4 receptor
|
|
IL5
|
interleukin 5
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
IL7
|
interleukin 7
|
|
IL7R
|
interleukin 7 receptor
|
|
IL9
|
interleukin 9
|
|
IL9R
|
interleukin 9 receptor
|
|
INCENP
|
inner centromere protein antigens 135/155kDa
|
|
IRAK4
|
interleukin-1 receptor-associated kinase 4
|
|
IRF4
|
interferon regulatory factor 4
|
|
IRF5
|
interferon regulatory factor 5
|
|
IRF8
|
interferon regulatory factor 8
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGAE
|
integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
JAM3
|
junctional adhesion molecule 3
|
|
JUNB
|
jun B proto-oncogene
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCNRG
|
potassium channel regulator
|
|
KDM6B
|
lysine (K)-specific demethylase 6B
|
|
KDR
|
kinase insert domain receptor
|
|
KDSR
|
3-ketodihydrosphingosine reductase
|
|
KIAA1524
|
KIAA1524
|
|
KIF2A
|
kinesin heavy chain member 2A
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KMT2D
|
lysine (K)-specific methyltransferase 2D
|
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin)
|
|
LDHA
|
lactate dehydrogenase A
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LEPQTL1
|
Leptin, serum levels of
|
|
LEPR
|
leptin receptor
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LIF
|
leukemia inhibitory factor
|
|
LITAF
|
lipopolysaccharide-induced TNF factor
|
|
LMO1
|
LIM domain only 1 (rhombotin 1)
|
|
LMO2
|
LIM domain only 2 (rhombotin-like 1)
|
|
LPL
|
lipoprotein lipase
|
|
LRP6
|
low density lipoprotein receptor-related protein 6
|
|
MAGEA3
|
melanoma antigen family A3
|
|
MALT1
|
MALT1 paracaspase
|
|
MAP3K14
|
mitogen-activated protein kinase kinase kinase 14
|
|
MAP4
|
microtubule-associated protein 4
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MCM3AP
|
minichromosome maintenance complex component 3 associated protein
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MEF2B
|
myocyte enhancer factor 2B
|
|
MEIS1
|
Meis homeobox 1
|
|
MERTK
|
MER proto-oncogene, tyrosine kinase
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFHAS1
|
malignant fibrous histiocytoma amplified sequence 1
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MICB
|
MHC class I polypeptide-related sequence B
|
|
MIR125B1
|
microRNA 125b-1
|
|
MIR126
|
microRNA 126
|
|
MIR127
|
microRNA 127
|
|
MIR142
|
microRNA 142
|
|
MIR143
|
microRNA 143
|
|
MIR146A
|
microRNA 146a
|
|
MIR146B
|
microRNA 146b
|
|
MIR150
|
microRNA 150
|
|
MIR155
|
microRNA 155
|
|
MIR15A
|
microRNA 15a
|
|
MIR16-1
|
microRNA 16-1
|
|
MIR17
|
microRNA 17
|
|
MIR181A2
|
microRNA 181a-2
|
|
MIR185
|
microRNA 185
|
|
MIR196B
|
microRNA 196b
|
|
MIR21
|
microRNA 21
|
|
MIR223
|
microRNA 223
|
|
MIR23A
|
microRNA 23a
|
|
MIR24-1
|
microRNA 24-1
|
|
MIR28
|
microRNA 28
|
|
MIR29B1
|
microRNA 29b-1
|
|
MIR320D1
|
microRNA 320d-1
|
|
MIR34A
|
microRNA 34a
|
|
MIR361
|
microRNA 361
|
|
MLH1
|
mutL homolog 1
|
|
MLLT11
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 11
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MNDA
|
myeloid cell nuclear differentiation antigen
|
|
MRE11A
|
MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MSC
|
musculin
|
|
MSH2
|
mutS homolog 2
|
|
MSN
|
moesin
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTR
|
5-methyltetrahydrofolate-homocysteine methyltransferase
|
|
MUM1
|
melanoma associated antigen (mutated) 1
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MZB1
|
marginal zone B and B1 cell-specific protein
|
|
NBN
|
nibrin
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NFKBIZ
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NKX2-5
|
NK2 homeobox 5
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOTCH1
|
notch 1
|
|
NOTCH2
|
notch 2
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NT5E
|
5'-nucleotidase, ecto (CD73)
|
|
NUCLEOLIN
|
nucleolin multifunctional protein
|
|
ONECUT2
|
one cut homeobox 2
|
|
ORC4
|
origin recognition complex, subunit 4
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY8
|
purinergic receptor P2Y, G-protein coupled, 8
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAX2
|
paired box 2
|
|
PAX5
|
paired box 5
|
|
PAX7
|
paired box 7
|
|
PAX8
|
paired box 8
|
|
PCDH10
|
protocadherin 10
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD1LG2
|
programmed cell death 1 ligand 2
|
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific
|
|
PDE7B
|
phosphodiesterase 7B
|
|
PEBP4
|
phosphatidylethanolamine-binding protein 4
|
|
PEG10
|
paternally expressed 10
|
|
PGR
|
progesterone receptor
|
|
PHB
|
prohibitin
|
|
PHLPP1
|
PH domain and leucine rich repeat protein phosphatase 1
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PIM3
|
Pim-3 proto-oncogene, serine/threonine kinase
|
|
PLAGL1
|
pleiomorphic adenoma gene-like 1
|
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific)
|
|
PLK1
|
polo-like kinase 1
|
|
PMS1
|
PMS1 postmeiotic segregation increased 1 (S. cerevisiae)
|
|
PNP
|
purine nucleoside phosphorylase
|
|
POLM
|
polymerase (DNA directed), mu
|
|
PON1
|
paraoxonase 1
|
|
POU2AF1
|
POU class 2 associating factor 1
|
|
POU2F2
|
POU class 2 homeobox 2
|
|
PPP2CA
|
protein phosphatase 2, catalytic subunit, alpha isozyme
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
|
PRDM2
|
PR domain containing 2, with ZNF domain
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKD3
|
protein kinase D3
|
|
PROM1
|
prominin 1
|
|
PRRC2A
|
proline-rich coiled-coil 2A
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN2
|
protein tyrosine phosphatase, non-receptor type 2
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PTPRJ
|
protein tyrosine phosphatase, receptor type, J
|
|
PTX3
|
pentraxin 3, long
|
|
PVT1
|
Pvt1 oncogene (non-protein coding)
|
|
RAD50
|
RAD50 homolog (S. cerevisiae)
|
|
RAG1
|
recombination activating gene 1
|
|
RAG2
|
recombination activating gene 2
|
|
RANBP2
|
RAN binding protein 2
|
|
RB1
|
retinoblastoma 1
|
|
RCSD1
|
RCSD domain containing 1
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RFTN1
|
raftlin, lipid raft linker 1
|
|
RHOH
|
ras homolog family member H
|
|
RIPK4
|
receptor-interacting serine-threonine kinase 4
|
|
RNF31
|
ring finger protein 31
|
|
ROR1
|
receptor tyrosine kinase-like orphan receptor 1
|
|
RPS6
|
ribosomal protein S6
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
|
S1PR2
|
sphingosine-1-phosphate receptor 2
|
|
SDC1
|
syndecan 1
|
|
SEC31A
|
SEC31 homolog A (S. cerevisiae)
|
|
SEMA4D
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D
|
|
SEPT10
|
septin 10
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINA9
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 9
|
|
SET
|
SET nuclear proto-oncogene
|
|
SF3B1
|
splicing factor 3b, subunit 1, 155kDa
|
|
SH2B3
|
SH2B adaptor protein 3
|
|
SH2D1A
|
SH2 domain containing 1A
|
|
SH3KBP1
|
SH3-domain kinase binding protein 1
|
|
SHH
|
sonic hedgehog
|
|
SHMT1
|
serine hydroxymethyltransferase 1 (soluble)
|
|
SIK2
|
salt-inducible kinase 2
|
|
SIRT1
|
sirtuin 1
|
|
SLAMF1
|
signaling lymphocytic activation molecule family member 1
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNAI2
|
snail family zinc finger 2
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOX11
|
SRY (sex determining region Y)-box 11
|
|
SP110
|
SP110 nuclear body protein
|
|
SPACA3
|
sperm acrosome associated 3
|
|
SPANXB1
|
SPANX family, member B1
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SPIB
|
Spi-B transcription factor (Spi-1/PU.1 related)
|
|
SPN
|
sialophorin
|
|
SPRED1
|
sprouty-related, EVH1 domain containing 1
|
|
SPRR1A
|
small proline-rich protein 1A
|
|
SPRY2
|
sprouty homolog 2 (Drosophila)
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STK11
|
serine/threonine kinase 11
|
|
STK38
|
serine/threonine kinase 38
|
|
STK39
|
serine threonine kinase 39
|
|
SYK
|
spleen tyrosine kinase
|
|
TARDBP
|
TAR DNA binding protein
|
|
TBC1D10C
|
TBC1 domain family, member 10C
|
|
TBL1XR1
|
transducin (beta)-like 1 X-linked receptor 1
|
|
TBX21
|
T-box 21
|
|
TCF3
|
transcription factor 3
|
|
TCL1A
|
T-cell leukemia/lymphoma 1A
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TLR5
|
toll-like receptor 5
|
|
TLR7
|
toll-like receptor 7
|
|
TLR9
|
toll-like receptor 9
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF13B
|
tumor necrosis factor receptor superfamily, member 13B
|
|
TNFRSF13C
|
tumor necrosis factor receptor superfamily, member 13C
|
|
TNFRSF14
|
tumor necrosis factor receptor superfamily, member 14
|
|
TNFRSF17
|
tumor necrosis factor receptor superfamily, member 17
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9
|
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNFSF9
|
tumor necrosis factor (ligand) superfamily, member 9
|
|
TNIP1
|
TNFAIP3 interacting protein 1
|
|
TNIP2
|
TNFAIP3 interacting protein 2
|
|
TNIP3
|
TNFAIP3 interacting protein 3
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPM3
|
tropomyosin 3
|
|
TPO
|
thyroid peroxidase
|
|
TRAF1
|
TNF receptor-associated factor 1
|
|
TRAF2
|
TNF receptor-associated factor 2
|
|
TRD
|
T cell receptor delta locus
|
|
TRG
|
T cell receptor gamma locus
|
|
TXN
|
thioredoxin
|
|
TXNIP
|
thioredoxin interacting protein
|
|
TYMS
|
thymidylate synthetase
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
UCK2
|
uridine-cytidine kinase 2
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
ULBP2
|
UL16 binding protein 2
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VPREB3
|
pre-B lymphocyte 3
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
WNT3A
|
wingless-type MMTV integration site family, member 3A
|
|
WWC1
|
WW and C2 domain containing 1
|
|
XBP1
|
X-box binding protein 1
|
|
XCR1
|
chemokine (C motif) receptor 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
YBX1
|
Y box binding protein 1
|
|
YY1
|
YY1 transcription factor
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
|
ZFYVE9
|
zinc finger, FYVE domain containing 9
|
|
ZMIZ1
|
zinc finger, MIZ-type containing 1
|
|
ZNF385B
|
zinc finger protein 385B
|
|
ZNF521
|
zinc finger protein 521
|